Topic: Reuters Group plc
LONDON (Reuters) - Britain's highest court upheld a patent on Wednesday on a gene sequence held by Human Genome Sciences related to its new lupus drug Benlysta, in a defeat for rival drugmaker Eli Lilly.The UK Supreme Court ruling chimes with similar ...
ZURICH (Reuters) - Swiss drugmaker Roche Holding said a mid-phase study found its ocrelizumab drug maintained significant reduction in disease activity for multiple sclerosis patients for almost two years, boosting its chances of success in late-stage trials."The study showed that the significant ...
NEW YORK (Reuters Health) - A new analysis of past studies concludes that there seems to be some link between multiple sclerosis and narrowed head and neck veins -- but more research is needed to be sure.The report, funded by Canadian Institutes ...
NEW YORK (Reuters) - Former U.S. Open champion Venus Williams withdrew from the last grand slam of the year on Wednesday, revealing she is suffering from an autoimmune disease.The former world number one quit the tournament before her second-round match against Germany's ...
NEW YORK (Reuters Health) - A new study provides more evidence that multiple sclerosis (MS) is not caused by a blood vessel condition, as some research has suggested.The new findings follow a study last month in which Dr. Ellen Marder from the ...
ZURICH (Reuters) - Swiss biotech company Actelion Ltd said on Tuesday a mid-stage study showed one of its drugs under development helped reduce new inflammatory brain lesions in a targeted group of multiple sclerosis patients.The study found Actelion's Ponesimod drug, a selective ...
NEW YORK (Reuters Health) - Despite a few well-publicized studies and many hopeful patients waiting for treatment, there is no good evidence that multiple sclerosis, or MS, is caused by a blood vessel condition, a fresh look at the medical literature finds.That ...
NEW YORK (Reuters Health) - TV, radio and print advertisements that warn parents about the signs of rare but dangerous immune diseases in children may be misdirected, researchers say.Their analysis, published today in Pediatrics, found that only a few of the ten ...
NEW YORK (Reuters Health) - A new research review strengthens the evidence that women with multiple sclerosis are about as likely as other women to have a healthy pregnancy -- without putting their own health at risk.The findings, reported in the obstetrics ...
NEW YORK (Reuters Health) - Although medical marijuana has been legalized in many U.S. states, people with multiple sclerosis should think twice before they start using the drug routinely, researchers say.In a small study published Monday, they found people with the nerve-damaging ...
